RESECTABLE PANCREATIC CANCER
Clinical trials for RESECTABLE PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Electric field therapy + chemo shows promise against pancreatic cancer
Disease control Recruiting nowThis study tests a wearable device that creates electric fields (TTFields) combined with two chemotherapy drugs (gemcitabine and nab-paclitaxel) for people with pancreatic cancer that can be removed by surgery. Participants wear the device at least 18 hours daily and receive chem…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Ashish Manne • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New combo before surgery may boost pancreatic cancer outcomes
Disease control Recruiting nowThis study tests whether giving chemotherapy and radiation before surgery can help surgeons remove all of the pancreatic cancer. About 30 adults with resectable pancreatic cancer will receive the drugs gemcitabine and nab-paclitaxel plus targeted radiation, then surgery, then mor…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: PHASE2 • Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Scientists hunt for clues to prevent a common complication after pancreatic cancer surgery
Knowledge-focused Recruiting nowThis study looks at 100 people who have had a Whipple procedure (pancreaticoduodenectomy) for cancers of the pancreas or nearby areas. The goal is to find factors before, during, and after surgery that raise the risk of a pancreatic fistula—a leak of digestive fluid that can caus…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: NA • Sponsor: Minia University • Aim: Knowledge-focused
Last updated Jul 02, 2026 03:00 UTC
-
Blood test may predict pancreatic cancer recurrence before scans
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test can find tiny bits of tumor DNA (ctDNA and eccDNA) in people with pancreatic cancer that can be surgically removed. The goal is to see if these tests can predict if the cancer will come back early and help doctors monitor patients m…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: NA • Sponsor: Copenhagen University Hospital at Herlev • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC